Main competitors
Consensus Analysts' target price evolution (4 months) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Average Target P. Objective/dr gap Nbr of analysts
- - - - - - -
2,047.35 +9.43%34
12,900 +11.25%12
1,463.62 +0.52%37
1,074.17 -2.33%30
227.65 -11.59%6
2,483.33 +3.39%12
2,497.27 +13.72%11
- - - - -
3,303.29 -1.26%14
150.5 -4.14%4
15.42 +64.83%5
- - - - -
164.24 +8.41%3
- - - 124.25 -6.16%1
- - 20.6 +31.04%1
- - - - -
- - - - -
Average 2,036.28 +9.01% 13
Weighted average by Cap. 4,396.86 +7.61% 21
Generic Pharmaceuticals